Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine

Chiara Retrosi; Roberta Vezzoni; Claudio Conforti; Paola Corneli; Giovanni Magaton-Rizzi; Iris Zalaudek; Nicola Di Meo

Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine

Acta Dermatovenerol Alp Pannonica Adriat. 2019 Dec;28(4):185-186.

Authors

Chiara Retrosi¹, Roberta Vezzoni¹, Claudio Conforti¹, Paola Corneli¹, Giovanni Magaton-Rizzi¹, Iris Zalaudek¹, Nicola Di Meo¹

Affiliation

¹ Department of Dermatology and Venereology, Trieste General Hospital, University of Trieste, Trieste, Italy.

PMID: 31855275

Abstract

The cutaneous adverse effects of gemcitabine include allergic skin rash frequently associated with pruritus, alopecia, sweating, dermatitis with boils, and ulcerations. We report the case of a patient that developed inflammation of seborrheic keratoses after gemcitabine treatment.

Publication types

Case Reports

MeSH terms

Adenocarcinoma of Lung / drug therapy
Aged
Antimetabolites, Antineoplastic / adverse effects*
Antimetabolites, Antineoplastic / therapeutic use
Deoxycytidine / adverse effects
Deoxycytidine / analogs & derivatives*
Deoxycytidine / therapeutic use
Drug Eruptions / etiology*
Female
Gemcitabine
Humans
Keratosis, Seborrheic / chemically induced*

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Gemcitabine